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The small GTPase Rho and mDia2, a Rho-regulated
actin nucleator, function as critical regulators of
cytokinesis in cultured cells. However, their involve-
ment in cytokinesis during mammalian development
remains unknown. Here, we generatedmice deficient
in mDia2 and examined the role of Rho signaling in
cytokinesis during development. mDia2-deficient
mice survive until embryonic day 11.5 (E11.5), exhibit
severe anemia with multinucleate erythroblasts, and
die in utero by E12.5. mDia2-deficient erythroid cells
differentiate normally, though in a delayed manner,
but exhibit cytokinesis failure with decreased accu-
mulation of F-actin in the cleavage furrow during
late differentiation from proerythroblasts. On the
other hand, inactivation of Rho induces cytokinesis
failure from the earlier progenitor stage. mDia2-defi-
cient erythroblasts, however, are able to enucleate
their nuclei. Our findings have thus revealed that
mDia2 functions critically in cytokinesis in vivo during
erythropoiesis and further suggest that the cytoki-
nesis mechanism in development diverges down-
stream of Rho. They also demonstrate that cytoki-
nesis and enucleation utilize different mechanisms.
INTRODUCTION
In animal cytokinesis, actin filaments accumulate around the
equator of a dividing cell in anaphase to form a ring-like appa-
ratus, called the contractile ring, and myosin-based contraction
of this ring physically separates a dividing cell into two in telo-926 Cell Reports 5, 926–932, November 27, 2013 ª2013 The Authorsphase (Green et al., 2012; Pollard, 2010). The small GTPase
Rho functions as a molecular switch of cytokinesis by recruiting
actin nucleators and preparing the contractile apparatus at the
siteof contraction (JordanandCanman, 2012). Two typesof actin
filaments, branched and unbranched, are formed in cells through
the action of actin nucleators, typically the Arp2/3 complex and
the formin family proteins, respectively (Firat-Karalar and Welch,
2011). Involvement of Rho and the Rho-regulated formin family
proteins in cytokinesis is conserved during evolution, Rho1p
and Bnil1p in budding yeasts, Rho-1 and Cyk-1 in worms, and
Rho1 and Diaphanous in flies (Balasubramanian et al., 2004). In
mammalian cells, Rho acts on the mDia family of formin proteins
for de novo formation of actin filaments (Narumiya and Yasuda,
2006). There are three isoforms of mDia: mDia1–mDia3 (Alberts
et al., 1998;Watanabe et al., 1997; Yasuda et al., 2004). Although
depletion of mDia1 and/or mDia3 does not interfere with cytoki-
nesis, cytokinesis failure occurs ondepletion ofmDia2 in cultured
cells (Watanabe et al., 2008), suggesting that the Rho-mDia2
signaling operates as a mechanism of cytokinesis in mammalian
cells. However, such analysis has been limited to cultured cells,
and the role of Rho-mDia pathway in cytokinesis in vivo remains
to be determined.We recently generatedmice deficient in mDia1
or mDia3 or both and found that these knockout (KO) mice
develop to adulthood (Sakata et al., 2007; Shinohara et al.,
2012), further indicating the importance of mDia2 for cytokinesis
in vivo. We have now generated mice deficient in mDia2 and
examined its role in cytokinesis during development.
RESULTS
Loss of mDia2 Leads to Embryonic Lethality
To investigate in vivo functions of mDia2, we disrupted the
murine mDia2 gene (Figures S1A–S1D). Whereas mDia2 hetero-
zygous-deficient (mDia2+/) mice were born healthy and fertile
Figure 1. Loss of mDia2 Leads to Embry-
onic Lethality
(A) Genotype analysis shows progeny from
mDia2/ intercross.
(B) Representative photographs show mDia2+/+,
mDia2+/, and mDia2/ embryos at various
developmental stages. Note that the fetal liver of
an mDia2/ embryo at E12 is anemic (indicated
by an arrow). Scale bars, 2 mm.
(C) Representative photographs show mDia2+/+
and mDia2/ yolk sacs at E11.5. Note that the
yolk sac of an mDia2/ embryo contains less
blood. Scale bars, 2 mm.
See also Figure S1.without any noticeable phenotype, all homozygous-deficient
(mDia2/) mice from mDia2+/ intercrosses died in utero (Fig-
ure 1A), indicating thatmDia2 is essential for embryonic develop-
ment. BecausemDia2 is essential for cytokinesis in cultured cells
(Watanabe et al., 2008), we suspected that mDia2/ embryos
die at an early developmental stage due to cytokinesis failure.
However, we found that mDia2/ embryos survived without
severe malformations in their body until embryonic day 10.5
(E10.5) after gestation (Figures 1B and S1E) and died in utero
around E12.5 (Figure 1A). mDia2/ embryos were found viable
at the expected Mendelian ratio at E11.5 but paler and smaller
than their wild-type littermates (Figures 1A and 1B). Although
the heart functioned normally, and the blood vessels in the yolk
sacs were formed normally in mDia2/ embryos (Movies S1
and S2; Figure S1E), their yolk sacs appeared to have a less
amount of blood than that of wild-type (Figure 1C), suggesting
the presence of anemia in mDia2/ embryos.
mDia2 Is Required for Fetal Erythropoiesis
In mouse embryos, primitive erythropoiesis, which is character-
ized by the production of nucleated erythrocytes, is initiated in
blood islands of the yolk sac at E7.5 (Palis et al., 2010). Although
peripheral blood at E11.5 contains mostly nucleated primitive
erythroblasts (Fraser et al., 2007), analysis of peripheral blood
in E11.5 mDia2/ embryos revealed that their circulating blood
cells were less in number than wild-type littermates, large, and
frequently binuclear or multinuclear (Figures 2A–2C, S2A, and
S2B), suggesting the primitive erythropoiesis failure in mDia2/
embryos. In addition to this primitive erythropoiesis, the defini-
tive erythropoiesis starts around E11.5 in the fetal liver, in which
amassive number of enucleated erythrocytes are produced from
erythroblasts (Baron et al., 2012). Hematopoietic stem cells in
fetal livers continuously replenish erythroid progenitors for the
production of erythrocytes during late gestation. We thereforeCell Reports 5, 926–932, Nhypothesized that mDia2 is involved
also in erythropoiesis in the fetal liver.
Erythroid progenitors and erythroblasts
in fetal liver can be distinguished by
examining surface markers such as
CD71 and Ter119 (Zhang et al., 2003)
(Figures S2C and S2D). Flow cytometry
of wild-type and mDia2/ fetal liver cells
at E11.5 showed that mDia2/ fetal livercontained a significantly less number of Ter119+ erythrocytes
and lower percentage of Ter119+/CD71+ cells than wild-type
control: 10.5% ± 5.5% (n = 4) and 22.5% ± 4.0% (n = 5) (p =
0.015), respectively (Figures S2E, 2D, and 2E). Probably reflect-
ing this reduction of the erythroblast population, the percentages
of Ter119/CD71+ erythroid populations were higher in the
mDia2/ fetal liver than the wild-type control (Figure 2D). These
results together suggest that mDia2 is required for both primitive
and definitive erythropoiesis.
mDia2 Is Required for Expansion of Differentiating
Erythroblasts
The above results suggest that mDia2 plays critical roles in
production of erythroid cells. To clarify at which step mDia2
regulates erythropoiesis, we first examined burst-forming unit
erythroids (BFU-Es) and more mature erythroid colony-forming
unit erythroids (CFU-Es) in the fetal liver at E11.5. Both types of
colonies were formed even in the absence of mDia2. However,
the colony numbers of BFU-Es and CFU-Es were significantly
lower in mDia2/ cells than those of mDia2+/ cells (Figure 3A),
and CFU-E colony formation was more severely reduced in
mDia2/ cells. These results suggest that mDia2 regulates
erythropoiesis preferentially downstream of CFU-E (Figure S2C).
We next used an in vitro culture system for erythroid cell differen-
tiation (Zhang et al., 2003) to examine erythropoiesis failure in
mDia2/ cells in more detail. Ter119 cells were purified from
fetal livers and cultured in the presence of erythropoietin
(EPO). In this system, proliferation and differentiation of erythroid
cells were examined by counting the cell number, Wright-
Giemsa staining, and flow cytometry analysis. Counting the
viable cell number revealed that proliferation was severely
impaired in mDia2/ fetal liver cells compared to the mDia2+/
cells (Figure 3B); the increase of the cell number was delayed
already at 12 hr and significantly suppressed at 24 and 36 hr.ovember 27, 2013 ª2013 The Authors 927
Figure 2. Impaired Erythropoiesis of mDia2
KO Embryo
(A) Wright-Giemsa staining of peripheral blood
from mDia2+/+ and mDia2/ embryos. Arrow-
heads show multinucleate erythroblasts. Scale
bars, 0.1 mm.
(B) Number of erythroblasts in total peripheral
blood from mDia2+/+ (n = 10) and mDia2/ (n = 7)
embryos at E11.5 is shown. Data are represented
as mean ± SEM. **p < 0.01 (Mann-Whitney U test).
(C) Percentages of multinucleate erythroblasts in
peripheral blood from mDia2+/+ or mDia2+/ and
mDia2/ embryos at E11.5 are presented. The
graph shows the mean ± SD of five independent
experiments, in each of which >200 cells were
examined. **p < 0.01 (Mann-Whitney U test).
(D) Flow cytometry shows fetal liver cells from
mDia2+/+ and mDia2/ embryos at E11.5. Propi-
dium iodide (PI)-positive dead cells were excluded
from the analysis. The representative of more than
three experiments is shown.
(E) Number of Ter119+ cells in fetal livers of
mDia2+/ (n = 6) and mDia2/ (n = 8) embryos at
E11.5 is shown. Data are represented as mean ±
SEM. *p < 0.05 (Mann-Whitney U test).
See also Figure S2.Concomitant with this suppression of cell proliferation, multinu-
cleate cells increased in number in mDia2/ cells from 12 to
36 hr of culture (Figures 3B–3D), suggesting that the prolifera-
tion defect was coupled with cytokinesis failure in mDia2/
cells. We next treated the Ter119mDia2+/ cells with cytocha-
lasin D for 12 hr and found that a much higher population of
cells (more than 80% of the cytochalasin D-treated cells)
became multinucleated at 12 hr (Figure S3A) than mDia2/
cells (15.8% ± 3.1%) (Figure 3D). These findings demonstrate
that cytokinesis occurs in the earlier stage of erythroid differen-
tiation through control of F-actin assembly and that the cytoki-
nesis at this stage is carried out without involvement of mDia2.
We therefore next wondered whether an upstream molecule,
Rho, is involved in the cytokinesis of the early stage of differen-
tiation by introducing a Rho-specific inhibitor, C3, into the cells.
Notably, 70% of the C3-treated cells became multinucleated at
12 hr (Figure S3B). These results suggest that Rho controls
cytokinesis from the earlier differentiation stage, whereas its
effector, mDia2, becomes important for cytokinesis in the later
stages of erythroid differentiation. We then used mDia2 siRNA.
Depletion of mDia2 induced multinucleation of cultured cells,
and Giemsa staining suggested that they were late-stage
erythroblasts (Figure S3C), confirming the cytokinesis failure in
mDia2/ cells. Notably, the number of activated caspase-3+
cells increased time dependently in the mDia2/ cell popu-
lation (Figure 3E), suggesting that decreased proliferation
and increased multinucleate cell number are associated with
apoptotic cell death. Indeed, signals of activated caspase-3928 Cell Reports 5, 926–932, November 27, 2013 ª2013 The Authorswere observed often in multinucleate
erythroblasts (Figure S3D).
To further identify the differentiation
step at which mDia2 deficiency impairsproliferation and induces apoptosis, we subjected cells of
0, 12, 24, and 36 hr of culture to flow cytometry analysis. In
control mDia2+/ cells, more than 90% of the population was
CD71high Ter119 at 12 hr of culture (Figure 3F), among which
most appeared as c-Kit (Figure S3E), indicating that they repre-
sent proerythroblasts (Dev et al., 2010). mDia2+/ cells were then
enriched in the Ter119+CD71+ c-Kit population in a time-
dependent manner at 24 and 36 hr, indicating that they differen-
tiated to polychromatic or orthochromatic erythroblasts (Figures
3F and S3E) (Zhang et al., 2003). On the contrary, although
mDia2/ cells were enriched in the CD71high Ter119 popula-
tion at 12 hr, there was a significantly less accumulation of these
cells in the Ter119+CD71+ population at 24 and 36 hr (Figure 3F).
Because the appearance of apoptotic cells was associated with
multinucleation and decreased viable cell number in mDia2/
cells, a smaller accumulation of this genotype of cells in the poly-
chromatic or orthochromatic erythroblast population suggests
that multinucleation either in the transition from proerythroblast
or during terminal differentiation induces apoptosis in these
populations.
To examine whether the loss of mDia2 affects expression
of erythroid differentiation characteristics in this process, we
analyzed expression of several erythroid-related genes. We
found no significant difference between mDia2+/+ or mDia2+/
and mDia2/ cells in expression of Slc4a1, Spna1, EpoR, and
Gata1 at 12 and 24 hr (Figure S3F). Interestingly, mDia2 expres-
sion increased during in vitro differentiation of erythroblasts, as
reported previously by Ji et al. (2008); its expression more than
Figure 3. Impaired Proliferation and Multi-
nucleation of mDia2 KO Erythroblasts dur-
ing Erythroid Differentiation In Vitro
(A) Quantification of BFU-Es and CFU-Es in the
fetal liver of mDia2+/+ or mDia2+/ and mDia2/
embryos. Colony assays were carried out with
5,000 cells prepared from the fetal liver of indicated
genotypes at E11.5. Data are mean ± SD from five
(BFU-Es) and three (CFU-Es) mice in each group.
**p < 0.01 and *p < 0.05 (Welch test).
(B–F) Erythroid differentiation of mDia2/ fetal
liver cells in vitro is shown. Ter119 erythroid pro-
genitor cells were purified from the fetal liver of
E11.5mDia2+/ or mDia2/ embryos and cultured
in medium containing EPO. Aliquots were taken
at 0, 12, 24, and 36 hr and subjected to analysis.
(B) Cell proliferation during in vitro erythroid dif-
ferentiation is shown. Data are mean ± SD from
three independent experiments.
(C) Wright-Giemsa staining of mDia2+/ or
mDia2/ erythroblasts at 24 and 36 hr culture.
Red arrows show multinucleate cells. Red and
white arrowheads show enucleating cells and
enucleated nuclei, respectively. Scale bars, 50 mm.
(D) Percentages of multinucleate cells during ery-
throid differentiation are presented. The graph
shows the mean ± SD of three independent exper-
iments, in each of which >200 cells were examined.
(E) Percentages of phosphorylated caspase-3
(pCaspase-3)-positive cells in mDia2+/ and
mDia2/ cells are shown. More than 200 cells
from mDia2+/ (n = 3) or mDia2/ (n = 4) embryos
at E11.5 were analyzed, and the results are rep-
resented as mean ± SD. *p < 0.05 (Welch test).
(F) Flow cytometry shows mDia2+/ and mDia2/
cells during erythroid differentiation. PI-positive
dead cells were excluded from the analysis.
See also Figure S3.tripled in 24 hr (Figure S3G). These results together suggest that
the loss of mDia2 does not directly block differentiation of eryth-
roblasts but affects proliferation of differentiating erythroblasts
possibly through cytokinesis failure.
mDia2 Is Essential for Cytokinesis but Not for
Enucleation of Erythroblasts
In the terminal stage of erythroid differentiation in mouse, one
proerythroblast cell undergoes three cycles of mitosis with
decreasing its cell size and sequentially generating basophilic,
polychromatic, and orthochromatic erythroblasts, of which the
latter finally expel their nuclei to produce reticulocytes (Hattan-
gadi et al., 2011; Liu et al., 2013). To analyze how the loss of
mDia2 affects terminal erythroid differentiation, we monitoredCell Reports 5, 926–932, Nthe process of cytokinesis during
erythroid differentiation by live-cell imag-
ing (Figure 4A). Cells from mDia2+/+ as
well as mDia2+/ fetal liver underwent
rounds of successful cell divisions with
decreasing their size (Figure 4A, top). On
the other hand, mDia2/ erythroblasts
frequently failed in cytokinesis by exhibit-ing aberrant contraction (Figure 4A, bottom). The cleavage
furrow was formed initially but got destabilized during contrac-
tion, and the ingression was then fused back, and the cell could
not complete cytokinesis (Figure 4A). Notably, smaller mDia2/
cells failed in cytokinesis more frequently than larger mDia2/
cells; the percentage of cytokinesis failure in mDia2/ cells
was 84.8% (n = 33) and 18.2% (n = 33) in smaller (<12.5 mm)
and larger cells (>12.5 mm), respectively. Given that erythroblasts
decrease their size during differentiation, these results suggest
that mDia2 plays an essential role in the cytokinesis of erythro-
blasts in the terminal stage of differentiation, i.e., of basophilic
or polychromatic erythroblasts. Because mDia2 induces F-actin
for the contractile ring in cultured mammalian cells (Watanabe
et al., 2008), we stained for mDia2 and F-actin in differentiatingovember 27, 2013 ª2013 The Authors 929
Figure 4. Analysis of Cytokinesis and
Enucleation in mDia2 KO Erythroblasts
(A) Live imaging shows cell division of in-vitro-
differentiated mDia2+/ (top) and mDia2/ (bot-
tom) erythroblasts. Fetal liver cells were isolated
from embryos at E11.5 and cultured in medium
containing EPO for 24 hr. Division of erythroblasts
was thenmonitored every 3min for 6 hr. Scale bars,
10 mm. White and black arrows show normal and
abnormalcontractionoferythroblasts, respectively.
(B) Localization of mDia2 in dividing wild-type
erythroblasts is shown. Wild-type erythroblasts in
cytokinesis at 24 hr culture were stained for mDia2
(green), a-tubulin (red), and DNA (blue). Examples
of more than 20 cells are shown. Scale bars, 5 mm.
(C–E) Abnormal localization of F-actin (C) and
impaired accumulation of F-actin at the cleavage
furrow (D and E) and in mDia2/ erythroblasts are
shown. Dividing erythroblasts from mDia2+/ and
mDia2/ fetal liver were stained for F-actin (red),
a-tubulin (green), and DNA (blue). Scale bars,
5 mm. In (E), fluorescence intensity at the cleavage
furrow in erythroblasts of 20 cells in each group
from two independent experiments was quantified
as described in Experimental Procedures. Data
are presented as mean ± SEM. ***p < 0.001
(Mann-Whitney U test).
(F–H) Analysis of enucleation in mDia2 KO eryth-
roblasts is shown. Ter119 erythroid progenitor
cells were isolated as described in Figure 3B and
cultured for 24 hr in medium containing EPO. The
cells were further cultured for another 16 hr (H) or
36 hr (F and G) in medium without EPO.
(F) Wright-Giemsa staining shows mDia2+/ and
mDia2/ erythroblasts. Small panels show
examples of enucleating and enucleated erythro-
blasts, and arrows and arrowheads indicate
ejected nuclei and enucleated cells, respectively.
Scale bars, 20 mm.
(G) Frequency of enucleation in mDia2/ eryth-
roblasts is presented. The graph shows the
mean ± SEM of three independent experiments, in
each of which >200 orthochromatic erythroblasts
were examined. **p < 0.05 (Welch test).
(H) Immunofluorescence shows enucleating erythroblasts from mDia2+/ and mDia2/ embryos. Cells were stained for F-actin and DNA. Arrowheads
and arrows indicate nuclei protruding from cells and accumulation of F-actin, respectively. Scale bars, 5 mm.
See also Figure S4.erythroid cells. mDia2 signals were observed at the cleavage
furrow (Figure 4B), where F-actin also localized, in wild-type
cells. On the other hand, in mDia2/ cells, F-actin accumulation
was either seen at aberrant sites or was severely impaired at the
cleavage furrow after ingression (Figures S4C–S4E). These re-
sults suggest that mDia2 is required for production of F-actin
at the proper position of the cleavage furrow in erythroblasts to
perform persistent contraction of the contractile ring during
cytokinesis.
We next examined enucleation in mDia2/ erythroblasts.
Enucleation occurs in two steps: the first is protrusion of the
nucleus, and the second is pinching off the protruded nucleus
(Palis, 2012). We found that multinucleate mDia2/ erythro-
blasts frequently showed protrusion of their nuclei (Figures 4F–
4H and S4A; Movie S3). Consistent with the notion that the
nuclear protrusion is carried out by the F-actin assembly, F-actin930 Cell Reports 5, 926–932, November 27, 2013 ª2013 The Authorsaccumulated at the boundary between the cytoplasm and the
protruded nuclei in mDia2/ erythroblasts as seen in mDia2
wild-type and mDia2+/ cells (Figure 4G). We then wondered if
mDia2/ multinucleate erythroblasts could complete enucle-
ation and found that there are big enucleated mDia2/ erythro-
blasts, though with reduced frequency compared to that of
mDia2+/ erythroblasts (Figures 4F and 4G). These results sug-
gest that mDia2 is not essential for the enucleation process
at least in vitro. In addition to mDia2/ cells, Rho-inactivated
multinucleate erythroblasts also showed nuclear protrusion in
enucleation (data not shown), suggesting that F-actin assembly
pathways other than Rho-mDia2 function in enucleation. We
therefore examined the effects of inhibitors of actin polymeriza-
tion and other small GTPases regulating F-actin assembly (Ji
et al., 2008; Konstantinidis et al., 2012; Wang et al., 2012). The
protrusion of nuclei and F-actin accumulation in multinucleate
mDia2/ cells were inhibited by treatment of the cells with cyto-
chalasin D, latrunculin A, and a Rac1 inhibitor (Figures S4B–S4D;
Movie S4). These results suggest that the Rac-dependent
F-actin assembly pathway functions in erythroblasts and that
Rho and mDia2 are dispensable in this process, indicating the
cooperation of multiple Rho GTPase signaling pathways to
ensure the successful production of erythrocytes (Ji et al.,
2008) (Figure S4E).
DISCUSSION
Here, we have revealed the essential role of mDia2 for cytoki-
nesis of erythroblasts during mouse development. Our main
findings are discussed below.
First, our study demonstrated that the Rho-mDia2 signaling
found in cultured cells (Watanabe et al., 2008) indeed functions
in cytokinesis in vivo and plays an essential role in develop-
ment. Our findings have thus revealed the involvement of an
actin nucleator in mammalian somatic cytokinesis in vivo.
Previous findings on the involvement of actin nucleators in
cytokinesis were limited to meiosis (Leader et al., 2002; Pfender
et al., 2011; Yi et al., 2011). Importantly, the cytokinesis failure
phenotype of mDia2-deficient mice was most evident during
erythropoiesis. Such erythropoiesis failure was not found in
either mDia1-deficient (Peng et al., 2007; Sakata et al., 2007)
or mDia3-deficient mice, although immunofluorescence signal
for mDia1 is observed in the cleavage furrow and midbody
of erythroblasts (S.W., unpublished data). These results indi-
cate that mDia2 rather than mDia1 and mDia3 functions
critically in erythroblast cytokinesis. Why the phenotype of
mDia2-deficient mice, the cytokinesis failure, is mainly ob-
served in erythropoiesis remains to be investigated. Because
similar erythropoiesis-specific cytokinesis failure is observed
in patients with congenital dyserythropoietic anemia, who
have a mutation in KIF23 (Liljeholm et al., 2013), one of the
important factors controlling RhoA in cytokinesis, these
results might reflect the high susceptibility of erythroid cells
to the defect in Rho signaling. We further identified the point
of the mDia2 action in cytokinesis at the stage of basophilic
and polychromatic erythroblasts. Because cell death is fre-
quently observed in multinucleate erythroblasts, the prolifera-
tion defect is most probably due to the cytokinesis failure of
erythroblasts, though we could not exclude additional mecha-
nisms. The impaired cytokinesis during erythroid differentiation
in mDia2/ cells might also delay the differentiation of erythro-
blasts. These results taken together suggest that the cytoki-
nesis failure in erythroblasts is the major cause of anemia in
mDia2/ mice, which finally results in the embryonic lethality
in the mice.
Second, and equally importantly, we discovered that mDia2
is not always essential for cytokinesis. Indeed, mDia2/
embryos developed until E11.5. We also found that cytokinesis
of erythroid progenitors is not sensitive to the loss of mDia2
but fails upon Rho inactivation and treatment with actin poly-
merization inhibitors. It is noteworthy that the frequency of
cytokinesis failure increased during erythroblast differentiation,
and although the full ingression of cleavage furrow was often
observed in mDia2/ erythroblasts of a relatively bigger sizeCein the early stage, no or little ingression was observed in more
differentiated, smaller erythroblasts. These results implicate an
alternative actin nucleator or F-actin assembly pathway down-
stream of Rho during cytokinesis of erythroid progenitor cells
and suggest that mDia2 replaces their role during erythroblast
differentiation. It is interesting in this respect that expression of
mDia2 more than tripled during this time.
Finally, we have revealed that cytokinesis and enucleation are
driven by different Rho-GTPase signaling mechanisms. Previ-
ously, Ji et al. (2008) reported that the percentage of enucleated
erythroblasts in mDia2 shRNA-treated cells was decreased and
suggested the involvement of mDia2 in enucleation. We also
found the similar decrease of the number of enucleated cells
from mDia2/ cells. However, we suggest that this is due to
the cytokinesis failure during erythroid differentiation, which
resulted in the decrease of orthochromatic erythroblasts and
increase in multinucleated cells. The multinucleation itself
might also affect the efficiency of enucleation due to the in-
crease in the number of nuclei in one cell, although multinu-
cleate mDia2/ erythroblasts could extrude their nuclei with
F-actin accumulation, albeit lower frequency, to give rise to
big enucleated cells. On the other hand, the nuclear protrusion
in mDia2/ erythroblasts was blocked by inhibition of Rac or
F-actin depolymerization, which is in accordance with the
previous reports by Ji et al. (2008) and Konstantinidis et al.
(2012). These results suggest the presence of other uncharac-
terized F-actin assembly mechanisms downstream of Rac in
the enucleation process.
In summary, we have identified the Rho-mDia2 pathway as the
conserved Rho-formin family protein axis in cytokinesis of
erythroblasts in vivo. Our study has further demonstrated that
mDia2 is not critical in cytokinesis of every type of cell and that
Rac utilizes yet unidentified actin-dependent mechanisms in
enucleation.
EXPERIMENTAL PROCEDURES
Hematological Analysis and In VitroDifferentiation of Erythroid Cells
Wehaveobtainedall thenecessarypermissions fromboardsof animal andDNA
experiments in Kyoto University and RIKEN CDB for the mice used in our
research. Fetal livers were isolated from E11.5–E12 embryos andmechanically
dissociated by pipetting with a 25G needle in Iscove’s Modified Dulbecco’s
Medium (IMDM) containing 2% FBS (STEMCELL Technologies). Single-cell
suspensions were prepared by passing the dissociated cells through a 25 mm
cell strainer (BDFalcon). In vitro erythroiddifferentiationwasperformedaccord-
ing to Zhang et al. (2003). In brief, fetal liver cells were labeled with biotin-
conjugated Ter119 antibody (BD Pharmingen), and Ter119 cells were purified
through MS column and Streptavidin MicroBeads (Miltenyi Biotec). Purified
cells were seeded with IMDM GlutaMAX (Invitrogen), 15% FBS (STEMCELL
Technologies), 200mg/mlholo-transferrin, 10mg/ml recombinant human insulin,
0.1mMb-mercaptoethanol (Invitrogen), 13penicillin-streptomycinmixedsolu-
tion (PS) (Nacalai Tesque), and 2 U/ml EPO (Roche) into a dish precoated with
50 mg/ml fibronectin (Sigma-Aldrich). The cells weremaintained at 37Cwith an
atmosphere containing 5% CO2. For Figures 4F–4H and S4, the medium was
replaced at 24 hr culture with IMDM GlutaMAX containing 20% FBS, 13 PS,
and 0.1 mM b-mercaptoethanol and further cultured for 12–36 hr.
Statistical Analysis
Data are presented as mean ± SD or SEM and were evaluated using indicated
statistical tests on Prism 4.0 software (GraphPad). A value of p < 0.05 was
considered statistically significant.ll Reports 5, 926–932, November 27, 2013 ª2013 The Authors 931
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